Polar Asset Management Partners Inc. Kodiak Sciences Inc. Transaction History

Polar Asset Management Partners Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.8 - $7.49 $1.02 Million - $4.26 Million	569,300 New	569,300 $1.02 Million
Q1 2022 May 16, 2022	SELL	$7.09 - $89.45 $148,890 - $1.88 Million	-21,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$81.97 - $106.94 $1.72 Million - $2.25 Million	21,000 New	21,000 $2.02 Million

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.